FCM
XENT

Flinton Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Flinton Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,324
Closed -$91K – 880
2018
Q1 		$91K Sell
2,324
-7,000
-75% -$256K ﹤0.01% 772
2017
Q4 		$302K Sell
9,324
-4,676
-33% -$140K 0.01% 559
2017
Q3 		$436K Sell
14,000
-1,736
-11% -$51.4K 0.02% 418
2017
Q2 		$440K Sell
15,736
-5,264
-25% -$119K 0.02% 407
2017
Q1 		$360K Hold
21,000
– – 0.01% 397
2016
Q4 		$254K Buy
+21,000
New +$272K 0.01% 418

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Flinton Capital Management's XENT Position: Q2 2018 in Review

Flinton Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 2,324 shares — an estimated $91K sold.

Flinton Capital Management first reported a position in XENT in Q4 2016 and held it in 6 quarters. The position peaked at $440K in Q2 2017. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • Flinton Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • Flinton Capital Management sold 2,324 Intersect ENT, Inc shares in Q2 2018, an estimated $91K.
  • Flinton Capital Management first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 6 quarters.
  • Flinton Capital Management's Intersect ENT, Inc position peaked at $440K in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Flinton Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.